Brief: Double Bond Pharmaceutical Receives EU Funding For SME Instrument Phase I
08/04/2019 07:53
April 8 (Reuters) - Double Bond Pharmaceutical International
AB (publ) DBPHAb.TE :
* DBP RECEIVES EU FUNDING SME INSTRUMENT PHASE I
* PROJECT UNDER NAME TARGLIO HAS NOW BEEN FUNDED WITH AMOUNT
OF
SEK 500,000
Source text for Eikon: ID:nWkr4jYzYP
Further company coverage: DBPHAb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University